Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

Related Articles by Review for PubMed (Select 19243239)

1.

Innate and adaptive immunity for the pathobiology of Parkinson's disease.

Stone DK, Reynolds AD, Mosley RL, Gendelman HE.

Antioxid Redox Signal. 2009 Sep;11(9):2151-66. doi: 10.1089/ARS.2009.2460. Review.

2.
3.

Pathogenesis of nigral cell death in Parkinson's disease.

Przedborski S.

Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S3-7. Review.

PMID:
15885625
4.

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

Tansey MG, Goldberg MS.

Neurobiol Dis. 2010 Mar;37(3):510-8. doi: 10.1016/j.nbd.2009.11.004. Epub 2009 Nov 10. Review.

5.

Immunological features of alpha-synuclein in Parkinson's disease.

Roodveldt C, Christodoulou J, Dobson CM.

J Cell Mol Med. 2008 Oct;12(5B):1820-9. doi: 10.1111/j.1582-4934.2008.00450.x. Epub 2008 Jul 30. Review. Erratum in: J Cell Mol Med. 2008 Dec;12(6B):2875.

6.

Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?

Ziv I, Offen D, Barzilai A, Haviv R, Stein R, Zilkha-Falb R, Shirvan A, Melamed E.

J Neural Transm Suppl. 1997;49:195-202. Review.

PMID:
9266428
7.

Inflammatory response in Parkinson's diseaseĀ (Review).

Yan J, Fu Q, Cheng L, Zhai M, Wu W, Huang L, Du G.

Mol Med Rep. 2014 Nov;10(5):2223-33. doi: 10.3892/mmr.2014.2563. Epub 2014 Sep 12. Review.

PMID:
25215472
8.

Glial reactions in Parkinson's disease.

McGeer PL, McGeer EG.

Mov Disord. 2008 Mar 15;23(4):474-83. Review.

PMID:
18044695
9.

Neuroinflammation in Parkinson's disease.

Lee JK, Tran T, Tansey MG.

J Neuroimmune Pharmacol. 2009 Dec;4(4):419-29. doi: 10.1007/s11481-009-9176-0. Epub 2009 Oct 10. Review.

10.

Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease.

Floor E.

Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):709-20. Review.

PMID:
10875434
11.

Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process?

Ziv I, Barzilai A, Offen D, Nardi N, Melamed E.

J Neural Transm Suppl. 1997;49:69-76. Review.

PMID:
9266415
12.

Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway.

Booij J, Berendse HW.

J Neurol Sci. 2011 Nov 15;310(1-2):40-3. doi: 10.1016/j.jns.2011.07.029. Epub 2011 Aug 15. Review.

PMID:
21840542
13.

Neural and immune mechanisms in the pathogenesis of Parkinson's disease.

Blandini F.

J Neuroimmune Pharmacol. 2013 Mar;8(1):189-201. doi: 10.1007/s11481-013-9435-y. Epub 2013 Feb 3. Review.

PMID:
23378275
14.

Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.

Qian L, Flood PM, Hong JS.

J Neural Transm. 2010 Aug;117(8):971-9. doi: 10.1007/s00702-010-0428-1. Epub 2010 Jun 23. Review.

15.

Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective.

Hornykiewicz O.

Clin Neurol Neurosurg. 1992;94 Suppl:S9-11. Review.

PMID:
1320533
16.

Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.

Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C, Eken J.

Biol Signals Recept. 2001 May-Aug;10(3-4):224-53. Review.

PMID:
11351130
17.

Does oxidative stress participate in nerve cell death in Parkinson's disease?

Hirsch EC.

Eur Neurol. 1993;33 Suppl 1:52-9. Review.

PMID:
8375433
18.

Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.

Isacson O, Bjorklund LM, Schumacher JM.

Ann Neurol. 2003;53 Suppl 3:S135-46; discussion S146-8. Review.

PMID:
12666105
19.

An inflammatory review of Parkinson's disease.

Orr CF, Rowe DB, Halliday GM.

Prog Neurobiol. 2002 Dec;68(5):325-40. Review.

PMID:
12531233
20.

Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease.

Dluzen DE, McDermott JL.

J Gend Specif Med. 2000 Sep-Oct;3(6):36-42. Review.

PMID:
11253381
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk